Birth Defects Res by Lopez, Keila N. et al.
Birth Defect Survival for Hispanic Subgroups
Keila N. Lopez1, Wendy N. Nembhard2, Ying Wang3, Gang Liu4, James E. Kucik5, Glenn 
Copeland6, Suzanne M. Gilboa7, Russell S. Kirby8, and Mark Canfield9,*
1Division of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, 
Texas
2Arkansas Reproductive Health Monitoring System, Arkansas Children's Research Institute & 
University of Arkansas for Medical Sciences, Little Rock, Arkansas
3Division of Data Analysis and Research, Office of Primary Care and Health System 
Management, New York State Department of Health, New York, New York
4Department of Epidemiology and Biostatistics, School of Public Health, University at Albany, 
State University of New York, Albany, New York
5Office of the Associate Director for Policy, Centers for Disease Control and Prevention, Atlanta, 
Georgia
6Michigan Department of Health and Human Services, Michigan Birth Defects Registry, Lansing, 
Michigan
7National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control 
and Prevention, Atlanta, Georgia
8Department of Community and Family Health, College of Public Health, University of South 
Florida, Tampa, Florida
9Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health 
Services, Austin, Texas
Abstract
Background—Previous studies demonstrate that infant and childhood mortality differ among 
children with birth defects by maternal race/ethnicity, but limited mortality information is 
published for Hispanic ethnic subgroups.
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Methods—We performed a retrospective cohort study using data for children with birth defects 
born to Hispanic mothers during 1999–2007 from 12 population-based state birth defects 
surveillance programs. Deaths were ascertained through multiple sources. Survival probabilities 
were estimated by the Kaplan-Meier method. Cox proportional hazards regression was used to 
examine the effect of clinical and demographic factors on mortality risk.
Results—Among 28,497 Hispanic infants and children with major birth defects, 1-year survival 
was highest for infants born to Cuban mothers at 94.6% (95% confidence intervals [CI] 92.7–96.0) 
and the lowest for Mexicans at 90.2% (95% CI 89.7– 90.6; p < .0001). For children aged up to 8 
years, survival remained highest for Cuban Americans at 94.1% (95% CI 91.8–95.7) and lowest 
for Mexican Americans at 89.2% (95% CI 88.7–89.7; p= .0002). In the multivariable analysis 
using non-Hispanic White as the reference group, only infants and children born to Mexican 
mothers were noted to have a higher risk of mortality for cardiovascular defects.
Conclusions—This analysis provides a better understanding of survival and mortality for 
Hispanic infants and children with selected birth defects. The differences found in survival, 
particularly the highest survival rates for Cuban American children and lowest for Mexican 
American children with birth defects, underscores the importance of assessing Hispanic ethnic 
subgroups, as differences among subgroups appear to exist.
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1. Introduction
Birth defects affect approximately 1 in 33 newborns and are a leading cause of infant 
mortality in the United States (Centers for Disease Control and Prevention, 2008; Heron et 
al., 2009). Birth defects are also a major contributor to pediatric hospitalizations, chronic 
childhood illness, and developmental disabilities (Utah Department of Health, n.d.). Given 
the heterogeneity of the U.S. population, it is important to understand how birth defects are 
affecting different racial/ethnic communities. Health disparities in both prevalence and 
survival are well described in non-Hispanic (NH) Black as well as Hispanic children with 
birth defects compared with NH-White children (Broussard et al., 2012; Centers for Disease 
Control and Prevention, 2010; Nembhard, Pathak, & Schocken, 2008; Nembhard et al., 
2011; Reddy et al., 2011; Yang et al., 2006). Previous analyses of survival differences using 
population-based data have largely been limited to large racial groups (e.g., Whites and 
Blacks) or combined minority groups and have rarely examined racial/ethnic survival 
differences across more than one type of birth defect. The few studies that have assessed 
multiple birth defects for maternal racial/ethnic groups, noted that researchers should 
conduct further studies of variations among Hispanic ethnic subgroups, as previous studies 
have suggested potential variations in outcomes among these subgroups (Kucik et al., 2014; 
Reichman & Kenney, 1998).
Hispanics are the fastest growing minority population in the United States, constituting 17% 
of the population (Brown, n.d.; State and County Quickfacts, n.d.), but are a very 
heterogeneous group with the largest proportions comprised of Mexicans, Puerto Ricans, 
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and Cubans (Motel & Patten, n.d.). Overall, pediatric studies stratified by these Hispanic 
ethnic subgroups are limited. One statewide study assessing low birth weight and preterm 
delivery in Hispanic subgroups demonstrated that the risk of preterm delivery and low birth 
weight differed among these groups (Reichman & Kenney, 1998). In one of the few studies 
assessing the prevalence of an array of major birth defects prevalence among broader 
Hispanic subgroups, the study noted that Hispanic mothers born in Mexico/Central America 
were more likely to deliver babies with spina bifida and anotia or microtia than their U.S.-
born counterparts (Ramadhani et al., 2009). Prevalence (but not survival) of birth defects 
among Hispanic ethnic subgroups was noted in one study, demonstrating that Mexican 
American children had a higher prevalence of anotia and microtia and Puerto Rican children 
had a higher prevalence of anencephaly (Canfield et al., 2014).
Obtaining information about Hispanic ethnic subgroups has been problematic in studies 
investigating survival among infants and children with birth defects that have relied on 
hospital discharge data, single institution medical records, or population-based surveillance 
data from a single state registry. These data sources typically do not have adequate sample 
sizes or sufficient subgroup variation to adequately evaluate this information among 
Hispanics. Also, while smaller studies have assessed birth defect prevalence and survival for 
Hispanic ethnic subgroups (Cohen, Friedman, Mahan, Lederman, & Munoz, 1993; 
Reichman & Kenney, 1998), there is a need for a large population-based study to explore 
survival of infants with birth defects among Hispanic ethnic subgroups.
The objectives of this study were to (a) evaluate survival of infants and children of Hispanic 
ethnic subgroups with selected major birth defects, and (b) identify potential demographic 
and clinical factors associated with survival.
2. Methods
2.1. Population studied
A retrospective, population-based cohort study was conducted on all live births (singletons 
and multiples) between 1999 and 2007 with selected major birth defects from 12 population-
based state birth defects surveillance programs that were pooled for larger collaborative 
studies of survival among all children with birth defects (Meyer et al., 2016; Wang et al., 
2015). The population-based systems used either active (four state birth defects surveillance 
programs) or passive (eight state birth defects surveillance programs) case finding 
methodologies to identify all potential cases within a defined catchment area. For active case 
finding methodology, birth defects cases are actively identified by individuals reviewing 
birth defects data; for passive case finding methodology, cases are reported by providers/
facilities or administrative/other data sets. Data for birth cohorts were included from 12 
states (Appendix A). Our data include 1-year survival from all years for all states. In the 
current analysis, we included infants born to Hispanic mothers, who were subcategorized 
into Mexican, Puerto Rican, Cuban, and Other (Central and South American and other and 
unknown Hispanic), and infants born to NH-White mothers. For the purposes of this article, 
infants and children born to Mexican, Puerto Rican, and Cuban mothers will be referred to 
as Mexican, Puerto Rican, and Cuban, including Hispanic Blacks, if any. The study protocol 
was approved by each state's Institutional Review Board.
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2.2. Determining birth defects
The International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-
CM) and British Paediatric Association (BPA) codes (Appendix B) were used to classify 
birth defects by each state program in our study. We selected birth defect categories based on 
the likelihood that these defects were consistently diagnosed during early infancy and 
ascertained by state surveillance programs, given that these programs were either actively 
surveilled or cases were reported by providers/facilities or administrative/other data sets 
(Canfield et al., 2014). If a child had any of these selected birth defects, information on any 
additional birth defects of the child were also included in the data set.
2.3. Vital statistics
Each state surveillance program linked their birth defect case information to state death 
certificate data files (follow-up ranging from 1 to 8 years) to obtain the vital status of the 
study cohort. For deceased children, programs provided the date of death, duration of life in 
days, and underlying cause of death. Eight states only used state death certificates to 
determine child and infant death. Other states used additional data sources to obtain vital 
status information included hospital discharge files, medical records, and the National Death 
Index. Two state programs also collected information on deaths among their residents from 
neighboring states' vital records.
2.4. Demographic data
Surveillance programs matched cases to state birth certificate records to obtain demographic 
and clinical characteristics. These included infant sex (male, female), birth weight (<2,500 
and ≥2,500 g), gestational age (<37 and ≥37 weeks), plurality (singleton, multiple births), 
method of delivery (vaginal, caesarean), maternal age (<34 and ≥35 years), maternal 
education (≤high school, > high school), maternal nativity (U.S.-born, foreign-born), marital 
status (married, single), prenatal care (yes, no), maternal prenatal cigarette smoking (yes, 
no), maternal diabetes of any type (yes, no), maternal residence at delivery (metropolitan, 
non-metropolitan [based on county of maternal residence], and state of residence), and 
maternal race/ethnicity (NH White, Hispanic [Mexican, Cuban, Puerto Rican, and Hispanic 
other]). The maternal race/ethnicity were obtained from birth certificates of the infants/
children through matching of the birth defect cases of the participating state birth defect 
surveillance programs to state vital records (birth certificates). The maternal race/ethnicity 
information in the birth certificate records are self-reported by mothers/fathers. All 12 
programs had complete data on Hispanic subgroups for all years of the study and all ethnic 
subgroups listed above.
2.5. Statistical analysis
Using the Kaplan-Meier Product Limit method, survival probabilities for infant (< 1 year of 
age) and early childhood (1–8 years of age) were calculated for individual defects by 
maternal race/ethnicity. Greenwood's method was used to calculate 95% confidence intervals 
(CI) for estimates of survival probabilities. Data from all 12 birth defect programs were used 
to calculate infant survival estimates. For the analyses of survival beyond infancy, 10 
programs' data were analyzed using data for those born during 1999–2005; Illinois and 
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Nebraska data were excluded because of unavailability of vital status beyond infancy. 
Additionally, the birth cohort for New Jersey was only through 2005, making this the last 
birth year to be included for all 10 programs in the analysis. Thus, the longest period of 
follow-up was 8 years.
An initial bivariate analysis of all the selected variables was performed to determine possible 
explanatory variables for inclusion in multivariable models. Multivariable analysis using 
Cox proportional hazards regression models was conducted to explore associations between 
the explanatory variables and survival, controlling for infant sex, gestational age, birth 
weight, maternal age, maternal metropolitan or nonmetropolitan county of residence at 
delivery, maternal nativity, maternal race/ethnicity, surveillance methodology (active or 
passive case ascertainment), maternal diabetes, plurality, prenatal care, method of delivery, 
and birth year. The proportionality assumption was examined in the Cox model. Children 
with more than one defect are represented in more than one defect category.
SAS Version 9.2 (SAS Institute, Cary, NC) was used for all statistical analyses.
3. Results
During the study period, the 12 programs ascertained cases among approximately 14 million 
live births (about 39% of all live births in the United States), with 98,833 infants identified 
as having at least one of the 21 selected birth defects. Of these, we identified 28,497 
Hispanic births (28.8% of all births with birth defects), with all cases having vital status data 
for the infancy period, thus all being included in the first year survival analysis. A total of 
18,342 cases who survived beyond infancy (≥1 year of age) were followed up to 8 years. Of 
all infants, we had 69.8% Mexican (n = 19,881), 7.1% Puerto Rican (n = 2,024), 2.7% 
Cuban (n = 773), and 20.4% Hispanic other (n = 5,819) (e.g., mothers from Central and 
South American countries) (Table 1). NH Whites were the referent group. A total of 2,688 
Hispanic infants (9.4%) died in infancy with a survival probability of 90.6% (95% CI: 90.2–
90.9); 4,165 (7.6%) of NH-White infants died in infancy, with a survival probability of 
92.4% (95% CI: 92.1–92.6). There were 202 Hispanic children (1.1%) who died during 
childhood with the survival probability of 98.9% (95% CI: 98.799.0); 327 NH-White 
children (0.9%) died during childhood, with the survival probability of 99.1% (95% CI: 
99.0–99.2). The highest infant survival probability was in Cubans at 94.6% (95% CI 92.7–
96.0), followed by NH Whites at 92.4% (95% CI 92.1–92.6). The lowest infant survival 
probability was in Mexicans at 90.2% (95% CI 89.7–90.6). Analysis outcome were not 
statistically different from combined surveillance systems when assessed individually by 
type of registry (active vs. passive).
As shown in Table 1, survival probability was higher for infants who were male, of 
gestational age >37 weeks, an only child, born to a nondiabetic mother, lived in a 
metropolitan area, were delivered vaginally, had prenatal care, and were born after 2002. For 
Hispanic children who survived beyond infancy, childhood (1–8 years old) survival 
probability was higher for children who were of gestational age >37 weeks, had a vaginal 
delivery, and were born after 2002.
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Figure 1 shows Kaplan-Meier survival curves for infants born between 1999 and 2005 from 
10 surveillance programs stratified by Hispanic ethnic groups and NH Whites. When 
compared to NH Whites, the 8-year survival probability was the highest for Cubans (94.1% 
[95% CI 91.8–95.7]), similar for NH Whites and Puerto Ricans, and significantly lower for 
Mexicans (89.2% [95% CI 88.7–89.7; p = .0002]).
Results from survival analysis of Hispanic children by birth defect category and Hispanic 
subgroup are shown in Table 2. For comparison, data for NH Whites were added. The lowest 
overall survival probability occurred for Mexican and Puerto Rican children (0–8 years old) 
with hypoplastic left heart syndrome (HLHS), 44.9% (95% CI 39.4–50.3) and 45.9% (95% 
CI 29.6–60.9), respectively. Mexican and Puerto Rican infants with HLHS also had the 
lowest survival probability. In addition, less than 70% survival was found among Mexican 
infants with encephalocele, atrioventricular septal defect, and omphalocele; Puerto Rican 
infants with an atrio-ventricular septal defect; and Cuban infants with an encephalocele and 
an atrioventricular septal defect.
In the multivariable analysis using NH White as the reference group (Table 3), only Mexican 
infants and children were noted to have a higher risk of mortality for cardiovascular defects: 
the hazard ratio (HR) of infant death was 1.8 for common truncus, 1.3 for transposition of 
great arteries, 1.6 for tetralogy of Fallot and aortic valve stenosis, and 1.4 for atrioventricular 
septal defect; the HR of childhood mortality (1–8 years old) was 2.2 for hypoplastic left 
heart syndrome. Cuban infants had a statistically significant higher risk of mortality for cleft 
palate without cleft lip (HR: 2.7). Puerto Rican infants and children have no significantly 
different HR in the listed defects except for gastroschisis with a HR of 9.5 and a very broad 
range of 95% CI, which is possibly due to small numbers.
4. Discussion
Our study used multistate pooled data for 21 selected major birth defects to determine 
associated survival estimates and mortality risk for infants and children born to mothers of 
three major Hispanic ethnic groups. We identified 28,497 Hispanics (28.8%) with birth 
defects, providing a sufficiently large sample size to identify factors associated with 
Hispanic infant and child survival for a broad range of major birth defects. We found that 
demographic and clinical factors associated with survival for Hispanic infants included 
infant sex, gestational age/birth weight, plurality, maternal age, maternal diabetes, 
geographic area, method of delivery, prenatal care, and birth period.
The majority of studies use broad racial/ethnic groups (e.g., Blacks and Hispanics) when 
assessing survival outcomes. Using an analytic category of “Hispanic” makes it impossible 
to detect any disparities across the heterogeneous Hispanic community. We investigated 
infant and child survival within Hispanic ethnicities after adjustment for regional variations 
and other covariates. We observed differences in mortality and survival risk analysis between 
Hispanic ethnic groups and NH Whites for selected congenital heart defects, gastrointestinal 
defects, oral clefts, and central nervous system defects. A recent study using similar data 
from the 12 state birth defects programs used in our study demonstrated elevated prevalence 
in birth defects not found to be of higher mortality in our study (Canfield et al., 2014). This 
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includes a 50% or higher prevalence of anotia or microtia for Mexicans and a higher 
prevalence of anencephaly for Puerto Ricans. Cubans had a lower or similar prevalence for 
all birth defects studied (Canfield et al., 2014). Another study examining congenital heart 
disease in the United States noted that no racial/ethnic difference was observed in the overall 
congenital heart disease prevalence in Hispanics except for atrial septal defects (not assessed 
in our study) (Egbe et al., 2014). Our study demonstrated specific increases in mortality risk 
for Mexican infants and children with common truncus, atrioventricular septal defects, and 
aortic valve stenosis, a finding not seen in Puerto Ricans or Cubans. Other studies have 
conflicting findings regarding increased gastroschisis prevalence in Hispanics (Kim, Wang, 
Kirby, & Druschel, 2013; Kirby et al., 2013). We found that rectal and large intestinal 
atresia/stenosis were associated with a higher risk of infant mortality for the three Hispanic 
ethnic groups, which has not been described in the literature previously. In general, it is 
difficult to compare our findings to those previously studies, given the lack of information 
available on the mortality or survival for Hispanic ethnic groups.
Perhaps most interesting is our finding of overall survival for children with birth defects 
from infancy through childhood. While literature reporting overall survival for several birth 
defects often demonstrates lower rates for Hispanics compared with NH Whites (Canfield et 
al., 2006; Yang et al., 2006), when separated into Hispanic ethnic groups, Cubans had a 
statistically significant higher survival than all groups, including NH Whites. Further, Puerto 
Ricans and NH Whites had similar survival rates. Thus, given that the Mexican ethnic group 
had the lowest rate of survival, it is possible that previous studies demonstrating lower 
survival in Hispanics were reflecting this specific community, and caution must be taken 
when generalizing survival rates to “Hispanics” (not accounting for ethnic differences).
This study has several important strengths. First, the large sample size supports relatively 
stable survival estimates for most phenotypes and risk factors examined. Also, the data were 
collected from population-based birth defect programs linked to vital records, which 
enhances the reliability and representativeness of the study population. Our study extends 
the findings of a previous study (Kucik et al., 2014) using a larger population to provide 
more detailed survival estimates and to compare the survival and mortality experience of 
infants across an array of phenotypes and risk factors, throughout infancy and early 
childhood for Hispanic ethnic subgroups.
Limitations of our study include incomplete ascertainment of deaths. While the majority of 
deaths were identified by matching the state birth to death certificate records, some deaths 
were ascertained from medical records at birth hospitals. Any child for whom there was no 
record of death was assumed to be alive. Although some children might have moved and 
died in another state, many states have agreements in place with neighboring states to report 
deaths back to the state of birth. Additionally, three of 12 programs utilized the National 
Death Index, thus deaths that occurred outside the state of maternal residence at delivery 
could be potentially captured. Missed deaths could result in an overestimation of the survival 
probabilities. Finally, there is some degree of uncertainty given the wide CI in risk of death 
for the Cuban population due to their smaller sample size, thus findings should be carefully 
interpreted.
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Also, of seven surveillance programs using passive case ascertainment methodologies, only 
three validate the accuracy of their birth defect case identification. The misclassification 
could introduce a bias in estimating the survival probabilities by assigning noncases as 
cases. However, we minimized this potential bias by selecting phenotypes that were, for the 
most part, consistently diagnosed. Moreover, the mortality risk estimates reported in the 
current study were adjusted for case ascertainment methods as well as other risk factors 
using multivariable regression.
Another potential limitation includes the possible lack of accuracy of coding race/ethnicity 
on birth certificates across programs, defects, and time periods, which could lead to a 
misclassification of Hispanic subgroups and impact findings from our study. We attempted 
to ameliorate this by using several sources that identify the patient race/ethnicity, such as 
birth and death certificates, and maternal self-report.
Another potential limitation is that our finding of differences in survival among infants with 
specific birth defects such as atrioventricular septal defects, cleft lip/palate, and omphalocele 
could be due, in part, to differences in the prevalence of trisomies (e.g., trisomy 13 or 18) or 
other chromosomal anomalies among the different Hispanic subpopulations.
Finally, we were unable to adjust for other important factors, such as timing and age at initial 
diagnosis, clinical severity, socioeconomic status, maternal education, and whether the child 
had an isolated or nonisolated malformation. Unfortunately, these variables were not 
consistently available from all surveillance systems, and thus these may serve as 
confounders for our data. We limited our findings to three Hispanic subgroups, as the 
remaining data consisted of heterogeneous countries from Central and South America whose 
limited information made it challenge to be accurately analyzed. Many other rapidly 
growing populations of Hispanics in the United States, such as those from Central and South 
American countries (Zong & Batalova, 2015) were not captured in our analyses.
In conclusion, our study provides important estimates of survival probability and mortality 
risk for infants and children up to 8 years with selected birth defects using population-based 
birth defects programs. Differences in survival probabilities and mortality risks for Hispanic 
subgroups were found for selected congenital heart defects, gastrointestinal defects, oral 
clefts, and central nervous system defects. Additionally, we found a survival advantage for 
Cuban infants and children with birth defects, a finding requiring further investigation into 
other potential confounders, including socioeconomic status of the different Hispanic 
subgroups, as well as with NH Whites. Future studies should be performed to further 
ascertain differences in other Hispanic subgroups, and potential contribution of other 
relevant factors to infant and childhood survival among all Hispanic subgroups.
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Appendix A
State Birth Cohort
State Birth years Death yearsa Live 
births 
with 
birth 
defects
Surveillance methodologyb Data source(s) used for 
ascertaining deaths
AZ 1999–2007 1999–2010 2,413 Active Death certificate, Medical 
records, hospital 
discharge files
CO 1999–2006 Not providedc 1,496 Passive Death certificate
FL 1999–2007 1999–2010 3,952 Passive Death certificate
GA 1999–2007 1999–2009 571 Active Death certificate, NDI
IL 1999–2006 1999–2007 1,562 Passive Death certificate
MA 2000–2007 2000–2008 374 Active Death certificate
MI 1999–2006 1999–2009 529 Passive Death certificate, NDI
NC 2003–2007 2003–2010 831 Passive Death certificate
NE 1999–2006d 1999–2007 201 Passive Death certificate
NJ 1999&ndash;2005d 1999–2006 1,253 Passive Death certificate
NY 1999–2007 1999–2008 1,142 Passive Death certificate
TX 1999–2007 1999–2009 14,173 Active Death certificate, Medical 
records, hospital 
discharge files
a
For records with death information beyond the cut-off death years, we treated them as alive.
bActive case finding methodology: birth defects cases are actively identified by individuals reviewing birth defects data. 
Passive case finding methodology: cases are reported by providers/facilities or administrative/other data sets.
cCO provided with age at death instead of death year.
dNE: 2007 births are excluded because they were not followed for a full year after birth; NJ: 2006–2007 births are excluded 
because they were not followed for a full year after birth.
Appendix B
Selected Major Birth Defects, ICD-9-CM codes, and 
CDC/BPA codes
Birth defects ICD-9-CM codes CDC/BPA codes
Central nervous system defects
 Spina bifida without anencephalus 741.0–741.9 w/o 740.0–740.1 741.00–741.99 w/o 740.00–740.10
 Encephalocele 742.0 742.00–742.09
Congenital heart defects
 Common truncus 745.0 745.00–45.01
 Transposition of the great arteries 745.10, .11, .12, .19 745.10, .11, .12, .19
 Tetralogy of Fallot 745.2 745.20–745.21, 746.84, 747.31
 Atrioventricular septal defect 745.60, .61, .69 w 758.0 745.60–745.69 w 758.00–758.09
 Atrioventricular septal defect (occurring 
without Down
syndrome) 745.60, .61, .69 
wo758.0
745.60–745.69 wo758.00–758.09
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Birth defects ICD-9-CM codes CDC/BPA codes
 Aortic valve stenosis 746.3 746.30
 Hypoplastic left heart syndrome 746.7 746.70
 Coarctation of aorta 747.10 747.10–747.19
Oral clefts
 Cleft palate without cleft lip 749.0 749.00–749.09
 Cleft lip with or without cleft palate 749.1, 749.2 749.10–749.29
Gastrointestinal defects
 Esophageal atresia/tracheoesophageal fistula 750.3 750.30–750.35
 Pyloric stenosis 750.5 750.51
 Rectal and large intestinal atresia/stenosis 751.2 751.20–751.24
Musculoskeletal defects
 Upper limb deficiencies 755.20–755.29 755.20–755.29
 Lower limb deficiencies 755.30–755.39 755.30–755.39
 Diaphragmatic hernia 756.6 756.610–756.617
 Gastroschisis 756.79 756.71
 Omphalocele 756.79 756.70
Chromosomal defects
 Trisomy 21 (Down syndrome) 758.0 758.00–758.09
ICD-9-CM 5 International Classification of Diseases, 9th Revision, Clinical Modifications; CDC/BPA 5 Centers for 
Disease Control and Prevention/British Pediatric Association Classification.
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Figure 1. Survival curves of children born with birth defects to Hispanic women in the United 
States, by Hispanic subgroups, 1999–2005s
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